|
|
Our ClientsVasoGenix Pharmaceuticals, Inc.
Vasogenix is a biomedical company focused on the clinical development of therapeutic drug products for the prophylactic prevention of life threatening ischemic events that occur during angioplasty and stinting procedures. VasoGenix’s core technology centers on CGRP, a 37-amino acid neuropeptide that is the most potent, naturally occurring vasodilator in the human body. |
|||||||||||||||||
| © 2004 Alliance for Technology Commercialization | Home | About ATC | Milestone Ventures | Services | Client Process | Our Clients | Client Application | Staff | News | Areas We Serve | Contact Us | Business Assistance Sites | Economic Development Referrals | |